Enoxaparin pharmacokinetics and pharmacodynamics in renal impairment

被引：0
|
作者：
Sanderink, GJ
Guimart, C
Jariwala, N
Shukla, U
Ozoux, ML
Boutouyrie, B
Hutman, HW
Gutierrez, M
Marbury, T
Preston, R
机构：
[1] Aventis Pharma, Antony, France
[2] Invest Grp, Miami, FL USA
[3] Invest Grp, Orlando, FL USA
[4] Invest Grp, Ft Lauderdale, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2001年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：229A / 229A
页数：1
相关论文
共 50 条
  • [1] The pharmacokinetics and pharmacodynamics of enoxaparin in endstage renal disease.
    Brophy, DF
    Martin, EJ
    Venitz, J
    Gehr, TWB
    Carr, ME
    PHARMACOTHERAPY, 2005, 25 (10): : 1463 - 1463
  • [2] Pharmacokinetics and pharmacodynamics of ranitidine in renal impairment
    K. M. Koch
    M. Liu
    I. M. Davis
    S. Shaw
    Y. Yin
    European Journal of Clinical Pharmacology, 1997, 52 : 229 - 234
  • [3] Pharmacokinetics and pharmacodynamics of ranitidine in renal impairment
    Koch, KM
    Liu, M
    Davis, M
    Shaw, S
    Yin, Y
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (03) : 229 - 234
  • [4] Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment
    Sanderink, GJCM
    Guimart, CG
    Ozoux, ML
    Jariwala, NU
    Shukla, UA
    Boutouyrie, BX
    THROMBOSIS RESEARCH, 2002, 105 (03) : 225 - 231
  • [5] THE PHARMACOKINETICS AND PHARMACODYNAMICS OF QUINAPRIL AND QUINAPRILAT IN RENAL IMPAIRMENT
    BEGG, EJ
    ROBSON, RA
    BAILEY, RR
    LYNN, KL
    FRANK, GJ
    OLSON, SC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (02) : 213 - 220
  • [6] THE PHARMACOKINETICS AND PHARMACODYNAMICS OF NICARDIPINE IN PATIENTS WITH RENAL IMPAIRMENT
    AHMED, JH
    ELLIOTT, HL
    GRANT, AC
    RODGER, RSC
    REID, JL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (01) : P145 - P146
  • [7] Effect of renal impairment on the pharmacokinetics and pharmacodynamics of desirudin
    Lefevre, G
    Duval, M
    Gauron, S
    Brookman, LJ
    Rolan, PE
    Morris, TM
    Piraino, AJ
    Morgan, JM
    Palmisano, M
    Close, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (01) : 50 - 59
  • [8] Pharmacokinetics and pharmacodynamics of evolocumab in patients with renal impairment
    Lee, E.
    Gibbs, J.
    Wasserman, S. M.
    Block, G.
    Emery, M. G.
    Abosaleem, B.
    Tracy, M.
    Gibbs, M.
    Somaratne, R.
    Kasichayanula, S.
    Hanafin, P.
    Egbuna, O.
    EUROPEAN HEART JOURNAL, 2016, 37 : 343 - 343
  • [9] Enoxaparin pharmacokinetics and pharmacodynamics in obese subjects
    Sanderink, GJ
    Le Liboux, A
    Jariwala, N
    Harding, N
    Ozoux, ML
    Shukla, U
    Montay, G
    Boutouyrie, B
    Miro, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 229A - 229A
  • [10] The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers
    Sanderink, GJ
    Le Liboux, A
    Jariwala, N
    Harding, N
    Ozoux, ML
    Shukla, U
    Montay, G
    Boutouyrie, B
    Miro, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (03) : 308 - 318
12345